The Federal Trade Commission and CVS Health have reached a proposed settlement over insulin pricing. On March 23, the FTC ...
UnitedHealth Group’s Optum Rx is monitoring three notable drug candidates that might be approved in the next few months, according to its winter 2026 report published Jan. 2. Two of the medications ...
Inside 2026 pharmacy market reveals retail dominance, PBM control, and ongoing consolidation shaping U.S. prescription drug ...
A new oral GLP-1 therapy and the first preventive option for COVID-19 are among the pipeline drugs that payers and plan sponsors should be watching this spring, according to a new report. The pipeline ...
CINCINNATI — A new lawsuit filed by Hamilton County accuses multiple drug manufacturers and pharmacy benefit managers of inflating the price of insulin and other diabetes medications. The suit, filed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results